Elsevier

Value in Health

Volume 18, Issue 7, November 2015, Page A424
Value in Health

PSS50 - A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy

https://doi.org/10.1016/j.jval.2015.09.574Get rights and content
Under an Elsevier user license
open archive

Cited by (0)